Loading...
Not a good buy right now for an impatient buyer. The chart is bullish, but momentum looks stretched (RSI ~77) with no proprietary buy signals and the latest quarter shows sharp YoY earnings deterioration. Better risk/reward likely comes on a pullback toward ~29.61 (pivot) or ~28.08 (S1) rather than buying at 30.23.
Trend/momentum: Bullish structure with moving averages aligned up (SMA_5 > SMA_20 > SMA_200) and MACD histogram positive and expanding (0.117), signaling continuing upside momentum. However, RSI_6 at ~77.46 is elevated (stretched/overbought conditions), which often precedes short-term pullbacks even within uptrends. Key levels: Pivot 29.608 (near-term line in the sand). Resistance R1 31.132 then R2 32.073. Support S1 28.083 then S2 27.142. Pattern-based forward bias (from similar candlesticks): next day has a 50% chance of -1.86% (short-term downside risk), while next week/month show upside probabilities (+7.77% week, +15.85% month), consistent with an uptrend but with near-term shakeout risk.
Intellectia Proprietary Trading Signals
Latest quarter: 2025/Q3. Growth trend was negative: Revenue 402.20M (-10.98% YoY). Profitability deteriorated sharply: Net Income 24.66M (-85.20% YoY) and EPS 0.05 (-84.85% YoY). Gross Margin 23.5 (-6.82% YoY). Overall, the quarter shows meaningful earnings compression and weakening operating performance.
No analyst rating or price target change data was provided, so there is no visible recent Wall Street consensus shift to support a decisive buy. Pros (if any) would be the ongoing technical uptrend; cons are the lack of supportive fundamental momentum (sharp YoY earnings drop) and no documented analyst/target upgrades.
